Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 665 | 233 | 12 |
Full Text Views | 55 | 2 | 0 |
PDF Downloads | 56 | 4 | 0 |
Hydroxychloroquine was given orally to 50 patients with P. vivax infections, either in a single dose or in a one-day treatment of several doses. Both parasitemia and temperature were controlled on the average in less than 2 days, with no unfavorable effects noted. This study in Venezuela confirms observations by others that hydroxychloroquine exhibits antimalarial activity against P. vivax comparable to that of other 4-aminoquinolines but appears to be better tolerated.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 665 | 233 | 12 |
Full Text Views | 55 | 2 | 0 |
PDF Downloads | 56 | 4 | 0 |